The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Marianne Pavel
Leadership - ENETS
Honoraria - AAA HealthCare; AAA HealthCare (Inst); Boehringer Ingelheim; Crinetics Pharmaceuticals (Inst); Esteve; Ipsen; Ipsen (Inst); ITM Isotope Technologies Munich; ITM Isotope Technologies Munich (Inst); Lilly; MSD; Novartis; Novartis (Inst); Recordati; Sanofi; SERB Pharmaceuticals; TaiRx, Inc.
Consulting or Advisory Role - AAA HealthCare; Esteve; Patient Advocate Foundation; SERB Pharmaceuticals; TaiRx, Inc.
Speakers' Bureau - AAA HealthCare; Boehringer Ingelheim; Ipsen; Lilly; MSD; Novartis; Recordati; Sanofi
Other Relationship - ESMO Open
 
Chris Verslype
Honoraria - AstraZeneca; Bayer; Ipsen; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; MSD; Roche
Speakers' Bureau - Bayer; Ipsen
Research Funding - Bayer (Inst)
Other Relationship - Pancreatic Cancer UK
 
Pedro Rocha
No Relationships to Disclose
 
Alastair Greystoke
Consulting or Advisory Role - AstraZeneca; BMSi; Boehringer Ingelheim; Foundation Medicine; Guardant Health; Janssen; Lilly; MSD Oncology; Novartis; Pfizer; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Bayer; Foundation Medicine; Janssen; Janssen; Janssen; Lilly; Merck Serono; Novartis; Pfizer; Pfizer; Roche; Sanofi
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Janssen; Roche; Takeda
 
Aman Chauhan
Stock and Other Ownership Interests - Elicio Therapeutics; Revolution Medicines
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Boehringer Ingelheim; Crinetics Pharmaceuticals; Curium Pharma; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck KGaA (Inst); Nano Therapeutics (Inst); Seneca Therapeutics (Inst); TerSera (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
 
Julia Koevi
Employment - Boehringer Ingelheim
 
Martha Mueller
Employment - Boehringer Ingelheim
 
Eric Song
Employment - Boehringer Ingelheim (China) Investment Co., Shanghai, China
 
Valeria Lifke
Employment - Boehringer Ingelheim
 
Emily Bergsland
Leadership - More Health (I)
Stock and Other Ownership Interests - exai bio (I); More Health (I)
Research Funding - Boehringer Ingelheim (Inst); Merck (Inst); RayzeBio (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
(OPTIONAL) Uncompensated Relationships - Lantheus Medical Imaging